Skip to content
Disclosery

EXANE DERIVATIVES: UUUU position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on UUUU, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 267,490 UUUU shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 267,490 shares
    Change vs previous 13F +68,262 shares

    0.75% of the 13F portfolio, value $1,311,770.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 199,228 shares
    Change vs previous 13F -65,434 shares

    0.52% of the 13F portfolio, value $1,831,708.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 264,662 shares
    Change vs previous 13F +190,714 shares

    0.49% of the 13F portfolio, value $2,011,879.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 73,948 shares
    Change vs previous 13F +12,000 shares

    0.13% of the 13F portfolio, value $515,080.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 61,948 shares
    Change vs previous 13F -58,785 shares

    0.07% of the 13F portfolio, value $316,023.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 120,733 shares
    Change vs previous 13F -107,684 shares

    0.21% of the 13F portfolio, value $685,642.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 228,417 shares
    Change vs previous 13F +4,602 shares

    0.29% of the 13F portfolio, value $968,158.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 223,815 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $371,088.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).